Literature DB >> 18548614

Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.

Michael R Loken1, Sung-Chao Chu, Wayne Fritschle, Michael Kalnoski, Denise A Wells.   

Abstract

The use of flow cytometric enumeration of blasts in bone marrow aspirates has been of limited value in situations where blood contamination of the specimen is present. Assessment of sequential pulls of bone marrow aspirates from the same patient show decreasing proportions of blasts that are detected in later specimens. To address this problem, the intensity of CD16 on maturing neutrophils was compared for bone marrow biopsies, peripheral blood, and bone marrow aspirates. A comparison between bone marrow biopsy and aspirate specimens from the same individuals showed similar proportions of neutrophils with mature phenotype in most, but not all pairs. Other cell populations (total mature lymphocytes, monocytes, neutrophils, and blasts) were also similar between the two specimen types, with one exception of a patient with myelodysplasia, exhibiting a unique blast population in the biopsy that was not evident in the aspirate. The proportion of mature myeloid cells expressing a mature neutrophil phenotype (high levels of CD16) was found to be 17% (±6.7, n=47) in trephine marrow biopsy specimens. In contrast, marrow aspirates contained more of the mature neutrophil phenotype (38%±16, n=33) with about 1/3 of the aspirates indistinguishable from biopsies. Using a simple formula to normalize the aspirate specimens to the average neutrophil composition of marrow biopsies, it was possible to correct for the dilutional effect of added blood to both normal bone marrow aspirates and aspirates with elevated blast counts. These results suggest three alternative means of circumventing the problem of blood dilution of marrow aspirate specimens. (1) Blast counts by flow cytometry can be obtained from disaggregated biopsy specimens. (2) A bone marrow aspirate can be assessed for the proportion of mature neutrophils present and only those with low proportions (<30%) of phenotypic mature neutrophils are considered adequate for blast counting. (3) The aspirates with high proportions of mature neutrophils may be normalized based on the proportion of dim CD16 maturing myeloid cells to a level observed in bone marrow biopsies (based on an average mature neutrophil composition). Such an approach for identifying the amount of hemodilution in each specimen may enhance the utility of flow cytometry in enumeration of blasts in bone marrow, especially in cases where myeloblast count is crucial for prognosis, such as myelodysplastic syndromes (MDS).
Copyright © 2008 Clinical Cytometry Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18548614     DOI: 10.1002/cyto.b.20429

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  20 in total

1.  Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.

Authors:  Kasiani C Myers; Elissa Furutani; Edie Weller; Bradford Siegele; Ashley Galvin; Valerie Arsenault; Blanche P Alter; Farid Boulad; Carlos Bueso-Ramos; Lauri Burroughs; Paul Castillo; James Connelly; Stella M Davies; Courtney D DiNardo; Iftikhar Hanif; Richard H Ho; Nicole Karras; Michelle Manalang; Lisa J McReynolds; Taizo A Nakano; Grzegorz Nalepa; Maxim Norkin; Matthew J Oberley; Etan Orgel; Yves D Pastore; Joseph Rosenthal; Kelly Walkovich; Jordan Larson; Maggie Malsch; M Tarek Elghetany; Mark D Fleming; Akiko Shimamura
Journal:  Lancet Haematol       Date:  2019-12-23       Impact factor: 18.959

2.  Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method.

Authors:  Elisabet E Manasanch; Dalia A Salem; Constance M Yuan; Nishant Tageja; Manisha Bhutani; Mary Kwok; Dickran Kazandjian; George Carter; Seth M Steinberg; Diamond Zuchlinski; Marcia Mulquin; Katherine Calvo; Irina Maric; Mark Roschewski; Neha Korde; Raul Braylan; Ola Landgren; Maryalice Stetler-Stevenson
Journal:  Leuk Lymphoma       Date:  2014-10-30

3.  Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy.

Authors:  Eric J Duncavage; Geoffrey L Uy; Allegra A Petti; Christopher A Miller; Yi-Shan Lee; Bevan Tandon; Feng Gao; Catrina C Fronick; Michelle O'Laughlin; Robert S Fulton; Richard K Wilson; Meagan A Jacoby; Amanda F Cashen; Lukas D Wartman; Matthew J Walter; Peter Westervelt; Daniel C Link; John F DiPersio; Timothy J Ley; John S Welch
Journal:  Blood       Date:  2017-01-12       Impact factor: 22.113

4.  Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals.

Authors:  Jairo M Montezuma-Rusca; Susan Moir; Lela Kardava; Clarisa M Buckner; Aaron Louie; Leo J Y Kim; Brian H Santich; Wei Wang; Olivia R Fankuchen; Gabriella Diaz; Janine R Daub; Sergio D Rosenzweig; Tae-Wook Chun; Yuxing Li; Raul C Braylan; Katherine R Calvo; Anthony S Fauci
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

5.  Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.

Authors:  Anna M Aalbers; Marry M van den Heuvel-Eibrink; Irith Baumann; Michael Dworzak; Henrik Hasle; Franco Locatelli; Barbara De Moerloose; Markus Schmugge; Ester Mejstrikova; Michaela Nováková; Marco Zecca; C Michel Zwaan; Jeroen G Te Marvelde; Anton W Langerak; Jacques J M van Dongen; Rob Pieters; Charlotte M Niemeyer; Vincent H J van der Velden
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

6.  A Novel Method to Assess Bone Marrow Purity is Useful in Determining Blast Percentage by Flow Cytometry in Acute Myeloid Leukemia and Myelodysplasia.

Authors:  A M Aldawood; Z Kinkade; F G Rosado; O A Esan; L F Gibson; J A Vos
Journal:  Ann Hematol Oncol       Date:  2015

Review 7.  Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria.

Authors:  Maria Sanz-De Pedro; Wei Wang; Rashmi Kanagal-Shamanna; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

8.  Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Authors:  Arjan A van de Loosdrecht; Canan Alhan; Marie Christine Béné; Matteo G Della Porta; Angelika M Dräger; Jean Feuillard; Patricia Font; Ulrich Germing; Detlef Haase; Christa H Homburg; Robin Ireland; Joop H Jansen; Wolfgang Kern; Luca Malcovati; Jeroen G Te Marvelde; Ghulam J Mufti; Kiyoyuki Ogata; Alberto Orfao; Gert J Ossenkoppele; Anna Porwit; Frank W Preijers; Stephen J Richards; Gerrit Jan Schuurhuis; Dolores Subirá; Peter Valent; Vincent H J van der Velden; Paresh Vyas; August H Westra; Theo M de Witte; Denise A Wells; Michael R Loken; Theresia M Westers
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

9.  Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.

Authors:  David A Jacobsohn; Michael R Loken; Mingwei Fei; Alexia Adams; Lisa Eidenschink Brodersen; Brent R Logan; Kwang Woo Ahn; Bronwen E Shaw; Morris Kletzel; Marie Olszewski; Sana Khan; Soheil Meshinchi; Amy Keating; Andrew Harris; Pierre Teira; Reggie E Duerst; Steven P Margossian; Paul L Martin; Aleksandra Petrovic; Christopher C Dvorak; Eneida R Nemecek; Michael W Boyer; Allen R Chen; Jeffrey H Davis; Shalini Shenoy; Sureyya Savasan; Michelle P Hudspeth; Roberta H Adams; Victor A Lewis; Albert Kheradpour; Kimberly A Kasow; Alfred P Gillio; Ann E Haight; Monica Bhatia; Barbara J Bambach; Hilary L Haines; Troy C Quigg; Robert J Greiner; Julie-An M Talano; David C Delgado; Alexandra Cheerva; Madhu Gowda; Sanjay Ahuja; Mehmet Ozkaynak; David Mitchell; Kirk R Schultz; Terry J Fry; David M Loeb; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2018-06-19       Impact factor: 5.742

10.  Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Authors:  Vlad Andrei Cianga; Lydia Campos Catafal; Petru Cianga; Mariana Pavel Tanasa; Mohamad Cherry; Phillipe Collet; Emmanuelle Tavernier; Denis Guyotat; Cristina Rusu; Carmen Mariana Aanei
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.